Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Ross Cagan(University of Glasgow), Tirtha K. Das(Icahn School of Medicine at Mount Sinai), Kevan M. Shokat(Howard Hughes Medical Institute)
Cited by 348
Related Papers
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
|PLoS Biology|2009|1.1k
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
|Annual Review of Biochemistry|2011|389
Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition
|Cell|2005|367
Formin Leaky Cap Allows Elongation in the Presence of Tight Capping Proteins
|Current Biology|2003|265